Aggressive tumor types and barriers to care contribute to unequal outcomes
by SPEAKIN’ OUT NEWS
Black women face a greater burden from aggressive uterine cancers and are about twice as likely to die from the disease as white women. The reasons are complex, and researchers have not fully explained them. Being Black alone does not determine an individual woman’s risk.
Black women are more often diagnosed with forms such as uterine serous carcinoma and carcinosarcoma, which can grow and spread quickly. Researchers still do not know why these types occur more frequently.
Insurance gaps, difficulty accessing specialists, provider bias, and dismissed symptoms can contribute to worse outcomes. These factors do not explain the entire disparity.
Fibroids and some aggressive tumor types can make ultrasound measurements less reliable. Persistent or recurring abnormal bleeding may require further evaluation, including an endometrial biopsy, even after a reassuring ultrasound.
A 2026 Kaiser Permanente study found that tumor characteristics explained most of the survival gap within its insured patient population. That finding reinforces that access to care alone does not explain the difference and that women should not be blamed for it.
“Our study found that the main driver of this disparity is tumor characteristics,” lead author Dr. Betty Suh-Burgmann said in the research announcement.
The most important warning sign is unusual vaginal bleeding: bleeding after menopause—even spotting—or bleeding between periods or periods that become unusually heavy. These symptoms often have noncancerous causes, but deserve prompt medical evaluation.
A normal Pap test does not rule out uterine cancer; Pap tests screen for cervical cancer. Women with continuing symptoms should ask what further testing is needed.